ReviewFrontiers in nutrition2026
Millet: a functional powerhouse against chronic lifestyle disease.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic lifestyle diseases such as cardiovascular disease, type 2 diabetes, and obesity are increasing globally, now accounting for more than two-thirds of deaths worldwide. In this context, millets are regaining attention as nutrient-dense, climate-resilient grains from traditional diets. They are rich in protein, dietary fiber, essential vitamins, minerals, and bioactive compounds that contribute to improved metabolic health and overall well-being. This review compiles and synthesizes current scientific evidence on the nutritional composition, bioactive profile, and disease-modulating mechanisms of millets. It also explores the role of millets in gut microbiome modulation, particularly their prebiotic potential in stimulating the production of short-chain fatty acids (SCFAs) and enhancing gut barrier integrity. Furthermore, the review highlights innovative food applications, including the incorporation of millets into modern food products such as fortified flours, breakfast cereals, snack bars, and beverages. Millets have demonstrated the ability to blunt postprandial blood glucose spikes by up to 15%, reduce cholesterol levels by nearly 10%, and promote natural calorie regulation, thereby supporting weight management and metabolic balance. Their prebiotic fibers nourish beneficial gut bacteria, contributing to improved gut health and immune defense. By integrating traditional knowledge with modern nutritional science, millets emerge as promising functional foods for preventing and managing chronic lifestyle disorders. Promoting millet-based diets offers a sustainable and health-promoting approach to address the growing burden of non-communicable diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.